Page 85 - Sohini Das

Cipla open to forge a partnership to distribute Covid-19 vaccines in India

The company already makes and markets antiviral drugs like remdesivir, favipiravir in India apart from importing and distributing Roche's tocilizumab (Actemra)

Covid-19: Dr Reddy's rolls out Sputnik V in India at Rs 995 per dose

The imported doses of the vaccine are priced at a maximum retail price of Rs 948 plus 5 percent GST per dose, with the possibility of a lower price point when local supply begins, says DRL

2 billion Covid-19 doses a long haul, but most will be covered by December

SII aims to make 50 million doses of Covovax (the Novavax vaccine) per month at its Pune plant

India's vaccine supplies to improve as it braces for Covid-19 third wave

India has vaccinated 37.2 million people with both doses of a vaccine, and about 135.5 million have received at least the first jab

Lupin willing to take partners to bring mRNA Covid-19 vaccines to India

Executive says company is looking for tie-ups to bring in drugs like Remdesivir

Bharat Biotech trial nod a turning point for paediatric Covid-19 vaccine

Bharat Biotech has already conducted trials on children 12 years and above

FabiFlu numero uno in Indian pharma market, show April sales data

With sales of Rs 352 crore in April, this brand alone accounted for over 2 per cent of the total domestic pharma market sales of Rs 15,662 crore

Russia's Sputnik V jabs set to make India debut at private hospitals

A large vaccine consignment is expected from Russia by third week of this month

Amid supply crunch, private hospitals eyeing import of Covid-19 vaccines

Two major hospital groups, Apollo Hospitals and Fortis Healthcare, said they are open to exploring opportunities to import

India's pharma market rebounds in April, clocks 51.5% sales growth

Low base of April 2020, pick-up in demand for Covid-19 drugs major contributors to growth

Access to foreign Covid-19 vaccine a long haul, say Indian companies

US pharmaceutical associations feel that the decision to support the patent waiver would weaken already-strained supply chains

Hospitals to reap the benefits of RBI's health care liquidity injection

While top hospital chains reported an average borrowing cost of 9.8% in H1FY21, loans under the special RBI liquidity window for the health care sector are expected to come at around 6%

RBI's Covid relief: Good move, but late, says health care industry

While some companies said they were open to borrowing, others felt their working capital cycle was comfortable

Hetero recalls a batch of its remdesivir brand Covifor after side effects

Some patients in Raigad district of Maharashtra developed side effects like fever and chills

Key Covid-19 bulk drugs see 180% price increase over four months

However, there is no shortage expected at the retail level anytime soon

Have got full advance for 110 mn doses, says Serum CEO Poonawalla

Poonawalla, who left for the UK recently, said in an interview that he was getting threatening calls from powerful people in India for delivering vaccine

Gujarat gets the lion's share of Covid vaccines on Day 1 of the new phase

Health ministry data shows a huge disparity in the doses that were given in just eleven states which could launch the drive on May 1 due to paucity of supply

Phase 3 of Covid vaccination in Maharashtra gets off to a slow start

Mumbai started vaccinations for everyone aged above 18 from around 2 pm at only five BMC-run centres, which had a target of 200 vaccinations per centre

Vax 3.0: Hospitals, states ready for a slow start for those above 18 years

Maharashtra, Gujarat and UP to begin vaccination today

Govt should have built safety stock of essential drugs: Kiran Mazumdar-Shaw

The Biocon founder and Executive Chairperson points out that drugs like Remdesivir should be allowed at home as an emergency step